Technology Portfolio: Therapeutic Angiogenesis - Arteriocyte Research and Development

Focused on Improving Patient Outcomes

Research & Development

Product Pipeline

Company Information

Research Areas Research Collaborations

Pipeline Technology Portfolio

Mission and Core Values Management Team Newsroom Contact Us

Corporate Homepage

Therapeutic Angiogenesis

Angiogenesis is a fundamental physiologic process involving the budding of new blood vessels from pre-existing vessels. It is a normal process for development and growth in the healthy body, for healing wounds and for restoring blood flow to tissues after injury or insult. However, in many serious disease states the process of angiogenesis is impaired, which results in complications such as ischemia (insufficient of blood supply), and/or delayed wound healing. Therapeutic angiogenesis is the process of using a drug or biologic agent to induce the creation of new blood vessels in injured tissue to reestablish normal blood flow.

Arteriocyte, an expert in therapeutic angiogenesis, is pursuing cell-based therapeutics and tissue engineering products for the treatment of ischemia and other disease conditions.

Arteriocyte, Inc.

Locations:

  Ohio Offices
  Cleveland
  Research & Development Center
  11000 Cedar Avenue
  Suite 270
  Cleveland, Ohio 44106, USA
  Phone: 216-658-3970

  Massachusetts Offices
  Hopkinton
  Eastern US Manufacturing
  and Distribution Center
  45 South Street
  Hopkinton, MA 01748, USA
  Phone: 508-497-8950

  Utah Offices
  Salt Lake City
  Tissue Engineering Center
  6440 South Wasatch Boulevard
  Salt Lake City, UT 84121, USA
  Phone: 866-660-2674

  Texas Offices
  Fort Worth
  Orthopedic Trauma Repair Center
  3400 Camp Bowie Boulevard
  Suite 212
  Fort Worth, TX 76107, USA
  Phone: 866-660-2674

  Maryland Offices
  Towson
  Malaria Initiative Center
  400 East Joppa Road
  Suite 416
  Towson, MD 21286, USA
  Phone: 866-660-2674

  E-mail: info@arteriocyte.com
  Phone: 1-866-660-AMSI(2674)
  Fax: (216) 721-1215